Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jackie R Glenn

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonistDavid Iyú, Jackie R Glenn, Ann E White, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Clopidogrel resistanceStan Heptinstall, Jackie R Glenn, Jane A May, et al.
Platelets|May 20, 2011
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMPDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|May 4, 2010
The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Thrombosis and Haemostasis|October 14, 2010
Mode of action of P2Y(12 ) antagonists as inhibitors of platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Prostaglandins & Other Lipid Mediators|November 25, 2010
PGE1 and PGE2 modify platelet function through different prostanoid receptorsDavid Iyú, Madlen Jüttner, Jackie R Glenn, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Arteriosclerosis, Thrombosis, and Vascular Biology|November 26, 2010
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonistDavid Iyú, Jackie R Glenn, Ann E White, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 27, 2004
Clopidogrel resistanceStan Heptinstall, Jackie R Glenn, Jane A May, et al.
Platelets|May 20, 2011
P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMPDavid Iyú, Jackie R Glenn, Ann E White, et al.
Platelets|May 4, 2010
The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Thrombosis and Haemostasis|October 14, 2010
Mode of action of P2Y(12 ) antagonists as inhibitors of platelet functionDavid Iyú, Jackie R Glenn, Ann E White, et al.
Prostaglandins & Other Lipid Mediators|November 25, 2010
PGE1 and PGE2 modify platelet function through different prostanoid receptorsDavid Iyú, Madlen Jüttner, Jackie R Glenn, et al.
Platelets|February 21, 2018
How does measurement of platelet P-selectin compare with other methods of measuring platelet function as a means of determining the effectiveness of antiplatelet therapy?Susan C Fox, Jane A May, Natalia Dovlatova, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Pageof 1